⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 15 in last 7 days 🍎 Food: 1 in last 7 days 🧸 Products: 52 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 2 hours ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 15 in last 7 days 🍎 Food: 1 in last 7 days 🧸 Products: 52 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 2 hours ago
🛡️ EUSW
💊 Medicines 🍎 Food 🧸 Products 🔎 Search
📊 Data
🏷 Brands 🌍 Countries ℹ️ About ✉ Unsubscribe
🇬🇧
🇬🇧 English 🇳🇱 Nederlands 🇫🇷 Français 🇩🇪 Deutsch 🇪🇸 Español 🇮🇹 Italiano 🇵🇹 Português 🇵🇱 Polski 🇸🇪 Svenska 🇷🇴 Română 🇨🇿 Čeština 🇫🇮 Suomi 🇩🇰 Dansk
💊 Medicine AT September 11, 2025

NovoRapid PumpCart 100 Einheiten/ml Injektionslösung in einer Patrone 100 U/ml (Injektionslösung)

📷 PubChem CID 16132418 · Source
NovoRapid PumpCart 100 Einheiten/ml Injektionslösung in einer Patrone 100 U/ml (Injektionslösung)
📷 PubChem CID 16132418 · Source
Parallel export of NovoRapid PumpCart 100 units/ml injection solution in cartridges is banned. Shortages in production caused this restriction.
🗄
Archived (older alert)
This alert was reported 319 days ago and has been moved from our active feed to the archive. The original safety information still applies — we have no confirmation from the issuing agency that the product is safe again. Refer to the official notice for the current status.
📈 Timeline
70 days in total
May 18, 2026 July 27, 2026
Daily snapshot data starts accumulating once the scheduler runs — for now this is interpolated from the agency's first/last dates.

What is this? This is a cartridge of insulin aspart. It is used to treat diabetes by helping control blood sugar.

What's happening? There is a shortage of this insulin. The company cannot make enough right now.

Does this affect me? If you use this insulin in Austria, you may have trouble finding it.

What should I do? Ask your pharmacist or doctor for help. They can suggest another insulin or a different supply.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Active substance(s)
INSULIN ASPART
Agency-published detail

🚫 Parallel export ban active · ATC: A10AB05 · Reason: Kapazitätsengpässe bei der Herstellung · Marketing authorisation holder: Novo Nordisk A/S, Novo Alle 1, 2880 Bagsvaerd, Kingdom of Denmark · Affected packs: 5 Stück Patrone, Schachtel [eingeschränkt verfügbar, since 2025-09-15, resupply 2026-12-31]

First published
September 11, 2025
Last refreshed by us
2 weeks ago
Severity (as classified)
Medium
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

❓ Frequently asked questions

▸ What is this medicine shortage alert about?
NovoRapid PumpCart 100 Einheiten/ml Injektionslösung in einer Patrone 100 U/ml (Injektionslösung). Parallel export of NovoRapid PumpCart 100 units/ml injection solution in cartridges is banned. Shortages in production caused this restriction.
▸ When was this alert issued?
This alert was issued on September 11, 2025 by BASG (Austria).
▸ Which countries are affected?
The alert applies to Austria.
▸ How serious is this alert?
Medium risk. A medium risk means harm is possible under certain conditions. Read the notice and act on the recommended steps.
▸ What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
▸ Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.